Global Api Market to Be Hampered by Stern Regulatory Policies in European Union

This report analyses the global market for active pharmaceutical ingredients for the period from 2012 to 2020. The market has been analyzed on the basis of type of API manufacturing (captive or in-house and contract manufacturing), type of active pharmaceutical ingredients (synthetic chemical API and biological API), type of drugs (branded or innovative prescription drugs, generic prescription drugs, and over-the-counter drugs), therapeutic areas, and by geography. The global API market is analyzed on the basis of therapeutic areas namely, NSAIDs, oncology drugs, diabetes drugs, cardiovascular drugs, central nervous system drugs, musculoskeletal drugs, and other drugs (such as antibacterial, antiviral, antifungal drugs, etc.). Also, the market for select NSAIDs (paracetamol, ibuprofen, aspirin, and naproxen) has alsbeen analyzed in detail in this report. The above mentioned segments are analyzed on the basis of market size in terms of USD million and their forecasts for the period 2014 to 2020 have alsbeen provided. The CAGR (%) for the segments have been estimated for the forecast period from 2014 to 2020, considering 2013 as the base year.

Request For Sample Report:-http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1690

The study is a robust combination of primary and secondary research. Primary research formed the bulk of our research efforts with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases. The report provides market size in terms of USD million for each segment for the period from 2012 to 2020, considering the macrand micrenvironmental factors. Growth rates for each segment within the global API market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and...